Skip to content
Clinical Trials – home
EstoniaBack to Estonia

Clinical trials in Paernu

11 clinical trials in Paernu, Estonia. Every trial is listed in the EU Clinical Trials Register and updated daily.

EstoniaOur site in EstoniaKliinilisedUuringud.ee(opens in a new tab)
Paernu at a glance
11
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

11 trials in Paernu

Open in trial search
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Pneumonia

Recruiting
Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Baloxavir Marboxil
  • Sponsor:University Of Oxford
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Merck Sharp & Dohme LLC

Colitis ulcerative

Not yet recruiting
Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting
Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Countries:EstoniaEstonia
  • Participants:0–17 years · 18–64 years
  • Substances:Colecalciferol
  • Sponsor:Diamyd Medical AB

Other cities in Estonia

The busiest research cities in the country

All 11 cities in Estonia

Clinical research in Paernu

What the registry says about research in the country

01 Diabetes Research

Groundbreaking research focusing on type 1 diabetes mellitus preservation therapy, investigating innovative treatments for newly diagnosed adolescents and adults. Studies aim to evaluate the effectiveness of new medications in preserving insulin production.

  • Beta cell function preservation
  • Glycemic control improvement
  • Autoimmune response management

Special attention is given to patients with specific genetic markers and antibody profiles.

02 Cardiovascular Health

Comprehensive studies targeting atherosclerotic cardiovascular disease and cholesterol management. Research focuses on innovative treatments to reduce major cardiovascular events and improve patient outcomes.

  • LDL-cholesterol reduction
  • Cardiovascular event prevention
  • Lipid management optimization

Trials evaluate both primary and secondary prevention strategies for heart disease.

03 Endocrine Disorders

Advanced research into thyroid eye disease treatment options, exploring new therapeutic approaches using innovative biological agents. Studies focus on improving symptoms and quality of life for affected individuals.

  • Proptosis management
  • Subcutaneous therapy evaluation
  • Vision preservation

Research emphasizes novel treatment delivery methods and their effectiveness.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).